MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Appistry, Inc., a leading provider of tools, software, and services that enable healthcare institutions to practice genomically enhanced medicine, today launched a cloud-based system for conducting patient-centered translational research. Appistry CloudDxSM Translational meets a critical need in clinical research centers: centralizing and coordinating data, processes, and communication in order to leverage institutional expertise and deliver high-quality results to patients and the research community.
In his talk at the Personalized Medicine World Conference in Mountain View, CA, today, Appistry Chief Medical Officer Dr. Cornelius F. Boerkoel described the need for a “communal” effort to combat disease. “Today, we have a broad range of tools for measuring and describing the loss of evolutionary homeostasis—all of the techniques available for studying the genome through next generation sequencing,” Boerkoel said. “But we’ll have achieved truly individualized medicine when we can integrate measures of developmental and physiological homeostasis. A system like CloudDx Translational lays the groundwork for that type of integration.”
Help employers find you! Check out all the jobs and post your resume.
In his talk at the Personalized Medicine World Conference in Mountain View, CA, today, Appistry Chief Medical Officer Dr. Cornelius F. Boerkoel described the need for a “communal” effort to combat disease. “Today, we have a broad range of tools for measuring and describing the loss of evolutionary homeostasis—all of the techniques available for studying the genome through next generation sequencing,” Boerkoel said. “But we’ll have achieved truly individualized medicine when we can integrate measures of developmental and physiological homeostasis. A system like CloudDx Translational lays the groundwork for that type of integration.”
Help employers find you! Check out all the jobs and post your resume.
